Hi [[ session.user.profile.firstName ]]

Growth Opportunities in the Healthcare Technology and Biosciences Sector

For most cities and states, the healthcare technology and biosciences sector is one of the most attractive industries of the future that can grow their communities. However, that attention attracts significant competition among players seeking to expand in a field that is highly complex. How should your community address this industry, and what is the best path to nurturing start-ups, retaining existing employers, attracting new companies and encouraging workforce development?

Key Takeaways:

• The healthcare technology and biosciences market is large and complex. Learn how the industry is structured and which segments might align best with your community.
• Cities and states across the country are all competing to grow their own biosciences economies. Find out what types of programs and strategies are the most effective.
• Come away with a simple model for assessing your own community’s strength relative to the healthcare technology and biosciences market.
Recorded May 14 2019 60 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Charlie Whelan, Vice President of Consulting, Transformational Health, Americas, Frost & Sullivan
Presentation preview: Growth Opportunities in the Healthcare Technology and Biosciences Sector

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Application of Harm Reduction Principles in Australia Recorded: Dec 5 2019 61 mins
    Mark Dougan, Director, Frost & Sullivan, Dr. Sud Agarwal, Professor Tikki Pangestu
    Harm reduction is a set of public health policies designed to lessen the social, economic, and physical consequences arising from various human behaviors, both legal and illegal. Along with demand reduction and supply reduction, harm reduction is an important harm minimization component in areas such as smoking and the use of illegal drugs, e.g., cannabis.

    In this Frost & Sullivan webinar, we will explore the application of harm minimization and more specific harm reduction measures in Australia. It will include how policies legalizing and regulating medicinal cannabis are impacting the consumption of non-regulated products, and the use of harm reduction approaches to minimize the effects of tobacco consumption.
  • Boost Your Company’s Growth with Frost & Sullivan’s 2020 Healthcare Predictions Recorded: Nov 12 2019 75 mins
    Reenita Das, Partner, Senior Vice President, Kamaljit Behera, Senior Industry Analyst, Frost & Sullivan
    Amid rising global trade tensions and a sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark during 2020. The new vision for healthcare for 2020 and beyond will not just focus on access, quality, and affordability but also on predictive, preventive, and outcome-based care models promoting social and financial inclusion.

    With the regulatory uncertainty on digital health applications slowly diminishing, incumbents will explore more focused healthcare applications during 2020. The convergence of artificial intelligence (AI), blockchain, and IoT will further catalyze the space of innovation adoption and related applications in the healthcare realm.

    To help shed light on trends, growth opportunities, and challenges to help you shape your healthcare strategy for 2020, Frost & Sullivan invites you to register for our highly anticipated annual webinar: Boost Your Company’s Growth with Frost & Sullivan’s 2020 Healthcare Predictions and Trends.

    The webinar is critical for the audience to understand:

    1. New opportunities connected to the pharmaceutical, biotechnology, medical technologies, diagnostics, and healthcare IT sectors.
    2. Opportunities that lie within advanced technologies, such as AI, blockchain, IoT, and cloud computing.
    3. Healthcare segments and geographic markets that will demonstrate tremendous growth opportunities during 2020.
    4. The top healthcare market predictions for 2020.
  • Leveraging Big Data to Drive Improved Healthcare Outcomes Recorded: Oct 22 2019 52 mins
    Siddharth Saha, Vice President of Research, Frost & Sullivan, Johnny Ma CTO of Health & Life Sciences, Hitachi Vantara
    As clinical data continues to grow rapidly in volume, variety, velocity and mobility, healthcare providers are looking for ways to capitalize on clinical data sets that exist within the system. Individual-level health data from direct (quantifiable) and indirect (quantifiable) sources enable better selection of disease targets and identification of patient populations, improving clinical outcomes through novel preventive and therapeutic approaches.

    This On-Demand webinar is moderated by Siddharth Saha, Vice President of Research Transformational Health Frost & Sullivan along with a subject-matter-expert in radiology imaging applications, Johnny Ma, CTO of Health & Life Sciences, Hitachi Vantara

    Learn About:

    • How to leverage big data to drive improved healthcare outcomes
    • Healthcare industry requirements in achieving the 2025 goals
    • Institutional considerations when owning and managing clinical data
    • Primary drivers of innovation
  • Cybersecurity in Healthcare: 3 Ways Organizations Can Mitigate Security Risks Recorded: Jul 25 2019 50 mins
    Mike Jude, Ph.D., Research Manager, Frost & Sullivan, Erin Benson, Director, Market Planning, LexisNexis Risk Solutions
    What is complicating healthcare cybersecurity?

    Solution providers need to articulate their value proposition, not only in business terms, but also in terms of the impact their technology will have on the delivery of healthcare and, ultimately, the wellbeing of the patient.

    Key Takeaways:

    • Identify primary barriers to establishing excellent healthcare cybersecurity.
    • What impact will IoT and cloud services, including computing and storage, have on healthcare cybersecurity?
    • What are the substantial growth opportunities?
  • Digital Health Predictions and Trends—What to Expect in 2020 Recorded: Jun 11 2019 56 mins
    Mike Jude (Moderator), Frost & Sullivan Digital Health Experts
    Are you curious about how Digital Health will change through the end of 2020? Are you looking for new growth opportunities to capitalize on now to ensure a successful future?

    We invite you to attend the complimentary webinar, Digital Health Predictions and Trends—What to Expect in 2020, moderated by Mike Jude, Ph.D., Research Manager, along with our Digital Health experts. They will provide expert insight and predictions on new developments poised to help you build a growth pipeline. Insights will be based on the likely impact of technologies such as AI, Big Data, predictive analytics, and telemedicine, as well as evolving areas such as new billing practices and Femtech. Learn about real-world success stories as well as potential mistakes you must avoid.

    Key Takeaways:
    • Learn what the digital health market potential is through 2020
    • Better understand which technologies and services will be the primary industry drivers in the short term
    • Identify growth opportunities in digital health
    • Explore the impact of new technologies and regulations on market potential
    • Gain insight on new approaches to achieve more efficient management of the healthcare process
  • Growth Opportunities in the Healthcare Technology and Biosciences Sector Recorded: May 14 2019 60 mins
    Charlie Whelan, Vice President of Consulting, Transformational Health, Americas, Frost & Sullivan
    For most cities and states, the healthcare technology and biosciences sector is one of the most attractive industries of the future that can grow their communities. However, that attention attracts significant competition among players seeking to expand in a field that is highly complex. How should your community address this industry, and what is the best path to nurturing start-ups, retaining existing employers, attracting new companies and encouraging workforce development?

    Key Takeaways:

    • The healthcare technology and biosciences market is large and complex. Learn how the industry is structured and which segments might align best with your community.
    • Cities and states across the country are all competing to grow their own biosciences economies. Find out what types of programs and strategies are the most effective.
    • Come away with a simple model for assessing your own community’s strength relative to the healthcare technology and biosciences market.
  • Future of Clinical Laboratories—Winning Strategies & Growth Opportunities Recorded: Mar 5 2019 64 mins
    Divyaa Ravishankar, Industry Principal,Frost & Sullivan, Kyle Fetter, Executive Vice President, XIFIN
    What are the winning strategies for a laboratory to be successful? This webinar will focus on the state of the clinical laboratories market in the US, Canada, and Europe. Given the reimbursement cuts, it is essential to understand how this can impact the revenue-generating abilities of clinical laboratories and what strategies they can take now to keep the business profitable.

    Frost & Sullivan invites you to join Divyaa Ravishankar, Industry Principal, Frost & Sullivan and Kyle Fetter, Executive Vice President & General Manager of Diagnostic Services, XIFIN, for the webinar: Future of Clinical Laboratories—Winning Strategies & Emerging Growth Opportunities. The event will provide an overview of the current state of clinical laboratories and recommendations for future success followed by an interactive, live question-and-answer session.

    Key Takeaways:

    • Understand what is driving business for clinical laboratories and what will change in the future
    • Learn how are clinical laboratories adjusting to the declining reimbursement situation
    • Gain insight on ways a data-driven approach can help laboratories increase efficiency
    • Better understand how blockchain applies in the world of clinical laboratory services testing
  • 2019 Life Science Predictions: Decoding 5 Incredible Growth Opportunities Recorded: Feb 6 2019 74 mins
    Nitin Naik, Unmesh Lal, Khushbu Jain, Fred Mao, Barbara Gilmore, Frost & Sullivan
    The Life Science industry is in a state of flux. While recent years have seen the advent of multiple novel technologies—such as IVF, CRISPR-Cas9, virtual clinical trials, and liquid biopsy—the industry today stands at a crossroads with challenges in scaling up and commercializing such technologies. The industry has now come to terms with new, path-breaking life science technologies that are helping make precision healthcare a reality. Chinese investments into the US biopharma industry jumped to $4.5 billion in 2018. An exclusive fireside chat with our US and China analysts will uncover trends in cross-border investments and growth opportunities in these two markets.

    Key Takeaways:

    • Establish the leading factors that will influence the size and direction of the global life sciences market in 2019.
    • Build clarity on technology developments in the global life sciences market in 2018 that will have an impact during 2019.
    • Identify the business models used to commercialize and distribute novel life science solutions.
    • Discover the key growth opportunities and strategic imperatives for companies in 2019.
Frost & Sullivan Webinar Series
Our Healthcare webinars cover Connected Health, Life Sciences, and Advanced Medical Technologies to help you to better understand buyer-seller dynamics as the healthcare system transitions to digital information, the pace at which new and innovative medical devices and systems are being adopted and getting embedded into the typical clinical pathway, both in mature and emerging markets and enables you to bring clarity to pharmaceutical/biotechnology, in-vitro diagnostics, and life science research tools market decisions and implementation tactics.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Growth Opportunities in the Healthcare Technology and Biosciences Sector
  • Live at: May 14 2019 3:00 pm
  • Presented by: Charlie Whelan, Vice President of Consulting, Transformational Health, Americas, Frost & Sullivan
  • From:
Your email has been sent.
or close